DAVID POPLACK to Adult
This is a "connection" page, showing publications DAVID POPLACK has written about Adult.
Connection Strength
0.142
-
A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancer. Cancer Res. 1995 Sep 15; 55(18):4069-72.
Score: 0.005
-
Differentiation stages of childhood acute lymphoblastic leukemias with p53 mutations. Leukemia. 1994 Jun; 8(6):963-7.
Score: 0.005
-
Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factor. J Clin Oncol. 1993 Sep; 11(9):1795-803.
Score: 0.005
-
Variability in the oral bioavailability of all-trans-retinoic acid. J Natl Cancer Inst. 1993 Jun 16; 85(12):993-6.
Score: 0.005
-
Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusion. Cancer Res. 1993 Mar 01; 53(5):1032-6.
Score: 0.004
-
Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule. Cancer Res. 1992 Feb 01; 52(3):521-4.
Score: 0.004
-
A phase II trial of continuous-infusion 6-mercaptopurine for childhood leukemia. Cancer Chemother Pharmacol. 1992; 30(2):155-7.
Score: 0.004
-
Current pharmacological treatment approaches to central nervous system leukaemia. Drugs. 1991 May; 41(5):702-16.
Score: 0.004
-
Pharmacologic approaches to the treatment of meningeal malignancy. Oncology (Williston Park). 1991 May; 5(5):107-16; discussion 123, 127.
Score: 0.004
-
Complications of leukemia. Pediatr Rev. 1991 Apr; 12(10):313-8.
Score: 0.004
-
Pediatric phase I trial and pharmacokinetic study of piritrexim administered orally on a five-day schedule. Cancer Res. 1990 Aug 01; 50(15):4464-7.
Score: 0.004
-
Phase II trial of sequential methotrexate and 5-fluorouracil with leucovorin in children with sarcomas. Invest New Drugs. 1990 May; 8(2):181-2.
Score: 0.004
-
Memory and learning sequelae in long-term survivors of acute lymphoblastic leukemia: association with attention deficits. Am J Pediatr Hematol Oncol. 1990; 12(2):174-81.
Score: 0.004
-
A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumors. Cancer Chemother Pharmacol. 1990; 26(5):343-4.
Score: 0.004
-
Pharmacokinetics of subcutaneous methotrexate. J Clin Oncol. 1988 Dec; 6(12):1882-6.
Score: 0.003
-
Bioavailability of low-dose vs high-dose 6-mercaptopurine. Clin Pharmacol Ther. 1988 May; 43(5):588-91.
Score: 0.003
-
A pediatric phase I and pharmacokinetic study of spirohydantoin mustard. Cancer Res. 1988 Apr 15; 48(8):2292-5.
Score: 0.003
-
Very high-dose methotrexate (33.6 g/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P. Leuk Lymphoma. 2006 Dec; 47(12):2488-504.
Score: 0.003
-
Leydig cell function in boys following treatment for testicular relapse of acute lymphoblastic leukemia. J Clin Oncol. 1985 Sep; 3(9):1227-31.
Score: 0.003
-
Very high dose cyclophosphamide with imidazole carboximide and vincristine sulfate in the treatment of stage IV neuroblastoma. Am J Clin Oncol. 1985 Jun; 8(3):210-4.
Score: 0.003
-
Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2. J Natl Cancer Inst. 2004 Oct 20; 96(20):1557-9.
Score: 0.002
-
Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia. J Pediatr. 1984 Feb; 104(2):182-6.
Score: 0.002
-
Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis. J Clin Oncol. 2003 Jan 01; 21(1):143-7.
Score: 0.002
-
Clinical pharmacology of 9-beta-D-arabinofuranosyladenine in combination with 2'-deoxycoformycin. Cancer Res. 1982 Sep; 42(9):3884-6.
Score: 0.002
-
Relationship of 5'-nucleotidase activity and antileukemic effect in 2'-deoxycoformycin therapy. Cancer Treat Rep. 1982 Feb; 66(2):387-90.
Score: 0.002
-
Levels of 2'-deoxycoformycin, adenosine, and deoxyadenosine in patients with acute lymphoblastic leukemia. Cancer Res. 1981 Nov; 41(11 Pt 1):4508-11.
Score: 0.002
-
Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia. Cancer Res. 1981 Sep; 41(9 Pt 1):3343-6.
Score: 0.002
-
Treatment of acute lymphoblastic leukemia in relapse: efficacy of a four-drug reinduction regimen. Cancer Treat Rep. 1981; 65 Suppl 4:93-6.
Score: 0.002
-
Pregnancy outcome following cancer chemotherapy. Am J Med. 1980 Dec; 69(6):828-32.
Score: 0.002
-
Leukoencephalopathy and elevated levels of myelin basic protein in the cerebrospinal fluid of patients with acute lymphoblastic leukemia. N Engl J Med. 1980 Jul 03; 303(1):19-21.
Score: 0.002
-
Improved treatment results in the management of single and multiple relapses of acute lymphoblastic leukemia. Cancer. 1980 Jun 15; 45(12):3090-4.
Score: 0.002
-
The detection of Fc-IgA receptors on T and non-T, non-B acute leukemic lymphoblasts. Cell Immunol. 1980 Jun; 52(1):218-22.
Score: 0.002
-
Characterization of lymphoblast Fc receptor expression in acute lymphoblastic leukemia. Blood. 1979 Jul; 54(1):285-91.
Score: 0.002
-
Diminished lymphoblast 5'-nucleotidase activity in acute lymphoblastic leukemia with T-cell characteristics. N Engl J Med. 1979 Jun 14; 300(24):1374-7.
Score: 0.002
-
Adrenal suppression after short-term corticosteroid therapy. Lancet. 1979 Mar 24; 1(8117):630-3.
Score: 0.002
-
Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma. Cancer. 1999 Jan 15; 85(2):511-6.
Score: 0.002
-
Hypothalamic-pituitary dysfunction following CNS prophylaxis in acute lymphocytic leukemia: correlation with CT scan abnormalities. Med Pediatr Oncol. 1979; 7(2):141-51.
Score: 0.002
-
Acute lymphoblastic leukemia followed by chronic myelocytic leukemia. Blood. 1978 Nov; 52(5):1033-6.
Score: 0.002
-
The Ommaya reservoir: newly recognized complications and recommendations for insertion and use. Cancer. 1978 Jun; 41(6):2431-7.
Score: 0.002
-
Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study. Clin Cancer Res. 1998 Feb; 4(2):357-60.
Score: 0.002
-
Characteristics of long-term survivors in AML. Med Pediatr Oncol. 1978; 5(1):219-23.
Score: 0.002
-
Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancers. J Clin Oncol. 1998 Jan; 16(1):181-6.
Score: 0.002
-
A pediatric phase I trial and pharmacokinetic study of thioguanine administered by continuous i.v. infusion. Clin Cancer Res. 1997 May; 3(5):713-7.
Score: 0.001
-
Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial. J Clin Oncol. 1997 Apr; 15(4):1538-43.
Score: 0.001
-
Phase II evaluation of topotecan for pediatric central nervous system tumors. Cancer. 1996 Aug 01; 78(3):527-31.
Score: 0.001
-
Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancer. J Clin Oncol. 1996 Mar; 14(3):774-82.
Score: 0.001
-
Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin. J Clin Oncol. 1996 Feb; 14(2):362-72.
Score: 0.001
-
Safety and efficacy of l-leucovorin rescue following high-dose methotrexate for osteosarcoma. Med Pediatr Oncol. 1995 Jun; 24(6):362-7.
Score: 0.001
-
Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule. J Clin Oncol. 1995 May; 13(5):1238-41.
Score: 0.001
-
The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemia. Leuk Res. 1994 Nov; 18(11):805-10.
Score: 0.001
-
Pharmacokinetics of taxol and doxorubicin administered alone and in combination by continuous 72-hour infusion. J Natl Cancer Inst. 1994 Jan 19; 86(2):143-5.
Score: 0.001
-
Pharmacokinetics of piroxantrone in a phase I trial of piroxantrone and granulocyte-colony stimulating factor. Cancer Res. 1993 Jun 01; 53(11):2587-90.
Score: 0.001
-
Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia. J Clin Invest. 1992 Feb; 89(2):640-7.
Score: 0.001
-
Subtle primary hypothyroidism in patients treated for acute lymphoblastic leukemia. Acta Endocrinol (Copenh). 1991 Apr; 124(4):375-80.
Score: 0.001
-
Characterization of immunoglobulin and T-cell receptor gene patterns in B-cell precursor acute lymphoblastic leukemia of childhood. J Clin Oncol. 1990 Mar; 8(3):431-42.
Score: 0.001
-
[Infectious complications from intraventricular route of administration in cancer patients]. Probl Med Wieku Rozwoj. 1990; 16:45-53.
Score: 0.001
-
Expression of the mdr-1/P-170 gene in patients with acute lymphoblastic leukemia. Blood. 1989 Sep; 74(4):1388-95.
Score: 0.001
-
Bioavailability of oral trimetrexate in patients with acquired immunodeficiency syndrome. Antimicrob Agents Chemother. 1988 Mar; 32(3):324-6.
Score: 0.001
-
Infectious complications of intraventricular reservoirs in cancer patients. Pediatr Infect Dis J. 1987 Feb; 6(2):182-9.
Score: 0.001
-
Attentional deficits in long-term survivors of childhood acute lymphoblastic leukemia (ALL). J Clin Neuropsychol. 1984 Aug; 6(3):325-36.
Score: 0.001
-
Inhibition of human lymphoproliferation by intravenous lipid emulsion. Clin Immunol Immunopathol. 1982 Nov; 25(2):196-202.
Score: 0.001
-
Phase II study of 5-azacytidine in sarcomas of bone. Am J Clin Oncol. 1982 Aug; 5(4):411-5.
Score: 0.001
-
Testicular function in boys after chemotherapy for acute lymphoblastic leukemia. N Engl J Med. 1981 May 07; 304(19):1121-4.
Score: 0.000
-
Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma. Am J Med. 1980 Apr; 68(4):486-91.
Score: 0.000
-
Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. Am J Med. 1979 Aug; 67(2):194-200.
Score: 0.000
-
Combined modality treatment of Burkitt's lymphoma. Cancer Treat Rep. 1978 Dec; 62(12):2031-4.
Score: 0.000
-
Correlation of adenosine deaminase activity with cell surface markers in acute lymphoblastic leukemia. J Clin Invest. 1978 Sep; 62(3):710-2.
Score: 0.000
-
Late soft tissue recurrence of acute lymphoblastic leukemia in a site of antecedent trauma. J Pediatr. 1978 May; 92(5):849-50.
Score: 0.000
-
"Concentration x time" methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms. Blood. 1978 May; 51(5):835-42.
Score: 0.000
-
Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapse. Cancer. 1978 Mar; 41(3):1059-63.
Score: 0.000
-
Blindness during remission in two patients with acute lymphoblastic leukemia: a possible complication of multimodality therapy. Cancer. 1977 Jan; 39(1):58-61.
Score: 0.000
-
Prolonged granulocytopenia from incompatible platelet transfusions. N Engl J Med. 1974 May 30; 290(22):1220-3.
Score: 0.000